Antibody Anti-SCGB2A1 used to explore the human lacrimal gland using organoids and single-cell sequencing
April, 2021 (Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences, University Medical Center Utrecht, Netherlands)
Treatment options for patients with lacrimal gland disorders are limited partly due to a lack of biological understanding.
Patient-derived organoids open up new avenues to study lacrimal gland biology and diseases.
Our secretoglobin antibody Anti-SCGB2A1 (HPA034584) is here used to explore the human lacrimal gland using organoids and single-cell sequencing.
Read more: http://ow.ly/cJ5o50E3ZTa